121 related articles for article (PubMed ID: 38215351)
1. Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer.
Stinchcombe TE; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Altorki N
J Clin Oncol; 2024 Apr; 42(10):1110-1113. PubMed ID: 38215351
[No Abstract] [Full Text] [Related]
2. Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance).
Altorki N; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Stinchcombe TE
J Thorac Cardiovasc Surg; 2024 Jan; 167(1):338-347.e1. PubMed ID: 37473998
[TBL] [Abstract][Full Text] [Related]
3. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
Altorki N; Wang X; Kozono D; Watt C; Landrenau R; Wigle D; Port J; Jones DR; Conti M; Ashrafi AS; Liberman M; Yasufuku K; Yang S; Mitchell JD; Pass H; Keenan R; Bauer T; Miller D; Kohman LJ; Stinchcombe TE; Vokes E
N Engl J Med; 2023 Feb; 388(6):489-498. PubMed ID: 36780674
[TBL] [Abstract][Full Text] [Related]
4. Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study.
Zhao K; Xia C; Qiu M; Yang Z; Cui T; Song T; Li S; Mei H; Zheng Y; Wang H
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16679-16690. PubMed ID: 37725243
[TBL] [Abstract][Full Text] [Related]
5. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
Altorki NK; Wang X; Wigle D; Gu L; Darling G; Ashrafi AS; Landrenau R; Miller D; Liberman M; Jones DR; Keenan R; Conti M; Wright G; Veit LJ; Ramalingam SS; Kamel M; Pass HI; Mitchell JD; Stinchcombe T; Vokes E; Kohman LJ
Lancet Respir Med; 2018 Dec; 6(12):915-924. PubMed ID: 30442588
[TBL] [Abstract][Full Text] [Related]
6. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
[TBL] [Abstract][Full Text] [Related]
7. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer.
Rice D; Kim HW; Sabichi A; Lippman S; Lee JJ; Williams B; Vaporciyan A; Smythe WR; Swisher S; Walsh G; Putnam JB; Hong WK; Roth J
Ann Thorac Surg; 2003 Oct; 76(4):1001-7; discussion 1007-8. PubMed ID: 14529975
[TBL] [Abstract][Full Text] [Related]
8. Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non-Small-Cell Lung Cancer.
Yue D; Xu S; Wang Q; Li X; Shen Y; Zhao H; Chen C; Mao W; Liu W; Liu J; Zhang L; Ma H; Li Q; Yang Y; Liu Y; Chen H; Zhang Z; Zhang B; Wang C
J Clin Oncol; 2022 Dec; 40(34):3912-3917. PubMed ID: 36027483
[No Abstract] [Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial.
Conte P; Bisagni G; Piacentini F; Sarti S; Minichillo S; Anselmi E; Aieta M; Gebbia V; Schirone A; Musolino A; Garrone O; Beano A; Rimanti A; Giotta F; Turletti A; Miglietta F; Dieci MV; Vicini R; Balduzzi S; D'Amico R; Guarneri V
J Clin Oncol; 2023 Nov; 41(32):4976-4981. PubMed ID: 37748109
[No Abstract] [Full Text] [Related]
11. Sublobar resection for metachronous stage I second primary non-small cell lung cancer: A single-centre experience.
Yotsumoto T; Fujimori S; Suzuki S; Kikunaga S; Niitsuma T
Lung India; 2024 Jan; 41(1):11-16. PubMed ID: 38160453
[TBL] [Abstract][Full Text] [Related]
12. Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer.
Kenmotsu H; Yamamoto N; Misumi T; Yoh K; Saito H; Sugawara S; Yamazaki K; Nakagawa K; Sugio K; Seto T; Toyooka S; Date H; Mitsudomi T; Okamoto I; Yokoi K; Saka H; Okamoto H; Takiguchi Y; Takahashi T; Tsuboi M
J Clin Oncol; 2023 Dec; 41(34):5242-5246. PubMed ID: 37656928
[No Abstract] [Full Text] [Related]
13. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
[TBL] [Abstract][Full Text] [Related]
14. Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC.
Leroy T; Monnet E; Guerzider S; Jacoulet P; De Bari B; Falcoz PE; Gainet-Brun M; Lahourcade J; Alfreijat F; Almotlak H; Adotevi O; Pernet D; Polio JC; Desmarets M; Woronoff AS; Westeel V
Lung Cancer; 2019 Nov; 137():23-30. PubMed ID: 31521979
[TBL] [Abstract][Full Text] [Related]
15. Prognostic study for survival outcome following the treatment of second primary lung cancer in patients with previously resected non-small cell lung cancer.
Wu Y; Han C; Chong Y; Liu J; Gong L; Wang Z; Liang N
Thorac Cancer; 2020 Oct; 11(10):2840-2851. PubMed ID: 32851789
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
Lee WR; Dignam JJ; Amin MB; Bruner DW; Low D; Swanson GP; Shah AB; D'Souza D; Michalski JM; Dayes IS; Seaward SA; Hall WA; Nguyen PL; Pisansky TM; Faria SL; Chen Y; Rodgers JP; Sandler HM
J Clin Oncol; 2024 May; ():JCO2302445. PubMed ID: 38759121
[No Abstract] [Full Text] [Related]
17. Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial.
Dai W; Wang Y; Liao J; Wei X; Dai Z; Xu W; Liu Y; Wang XS; Pompili C; Yu H; Pu Y; Zhao Y; Cao B; Wang Q; Feng W; Zhang Y; Liu F; Deng Y; Zhou J; Li J; Xie S; Xiang R; Wang X; Tian B; Yang X; Hu B; Liu X; Xie T; Yang X; Zhuang X; Qiao G; Li Q; Shi Q
J Clin Oncol; 2024 Jun; 42(18):2126-2131. PubMed ID: 38574304
[No Abstract] [Full Text] [Related]
18. Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
Novello S; Kowalski DM; Luft A; Gümüş M; Vicente D; Mazières J; Rodríguez-Cid J; Tafreshi A; Cheng Y; Lee KH; Golf A; Sugawara S; Robinson AG; Halmos B; Jensen E; Schwarzenberger P; Pietanza MC; Paz-Ares L
J Clin Oncol; 2023 Apr; 41(11):1999-2006. PubMed ID: 36735893
[No Abstract] [Full Text] [Related]
19. Patterns of Disease Recurrence after SABR for Early Stage Non-Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy.
Verstegen NE; Lagerwaard FJ; Hashemi SM; Dahele M; Slotman BJ; Senan S
J Thorac Oncol; 2015 Aug; 10(8):1195-200. PubMed ID: 26200274
[TBL] [Abstract][Full Text] [Related]
20. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; Hillman SL; Heron DE; Meyers BF; DiPetrillo TA; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB
J Clin Oncol; 2014 Aug; 32(23):2456-62. PubMed ID: 24982457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
